Scandinavian Journal of Rheumatology

Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus
pp. 85-95(11)
Author: Mok, C. C.

Lower urinary tract symptoms in female patients with rheumatoid arthritis
pp. 96-101(6)
Authors: Lee, K‐L.; Chen, M‐Y.; Yeh, J‐H.; Huang, S‐W.; Tai, H‐C.; Yu, H‐J.

Drug survival and reasons for discontinuation of intramuscular methotrexate: a study of 212 consecutive patients switching from oral methotrexate
pp. 102-106(5)
Authors: Linde, L.; Hetland, M. L.; Østergaard, M.

Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy
pp. 107-111(5)
Authors: Dahlqvist, S. Rantapää; Engstrand, S.; Berglin, E.; Johnson, O

Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis
pp. 112-116(5)
Authors: Lopez‐Olivo, M. A.; Gonzalez‐Lopez, L.; Garcia‐Gonzalez, A.; Villa‐Manzano, A. I.; Cota‐Sanchez, A. R.; Salazar‐Paramo, M.; Varon‐Villalpando, E.; Cardona‐Muñoz, E. G.; Gamez‐Nava, J. I.

The Rheumatoid Arthritis Quality of Life (RAQoL) for Sweden: adaptation and validation
pp. 117-123(7)
Authors: Hedin, P‐J.; McKenna, S. P.; Meads, D. M.

Killer cell immunoglobulin‐like receptor gene's repertoire in rheumatoid arthritis
pp. 124-127(4)
Authors: Yen, J. ‐H.; Lin, C. ‐H.; Tsai, W. ‐C.; Wu, C. ‐C.; Ou, T. ‐T.; Hu, C. ‐J.; Liu, H. ‐W.

Atherosclerosis in Asian Indians with systemic lupus erythematosus
pp. 128-132(5)
Authors: Bhatt, S. P.; Handa, R.; Gulati, G. S.; Sharma, S.; Pandey, R. M.; Aggarwal, P.; Ramakrishnan, L.; Shankar, S.

Endothelin‐1 serum levels correlate with MCP‐1 but not with homocysteine plasma concentration in patients with systemic sclerosis
pp. 133-137(5)
Authors: Peterlana, D.; Puccetti, A.; Caramaschi, P.; Biasi, D.; Beri, R.; Simeoni, S.; Corrocher, R.; Lunardi, C.

Hand radiology characteristics of patients carrying the T 303 M mutation in the gene for matrilin‐3
pp. 138-142(5)
Authors: Eliasson, G. J.; Verbruggen, G.; Stefansson, S. E.; Ingvarsson, T.; Jonsson, H.

Systemic vasculitis associated with Fasciola hepatica infection
pp. 143-146(4)
Authors: Llanos, C.; Soto, L.; Sabugo, F.; Gallegos, I.; Valenzuela, O.; Verdaguer, J.; Cuchacovich, M.

A large ulcer and cutaneous small‐vessel vasculitis associated with syphilis infection
pp. 147-151(5)
Authors: Chao, Y‐C.; Chen, C‐H.; Chen, Y‐K.; Chou, C‐T.

Epstein–Barr virus‐associated mononucleosis caused by weekly low‐dose methotrexate therapy in a rheumatoid arthritis patient
pp. 152-153(2)
Authors: Shoda, H.; Nakazaki, K.; Izutsu, K.; Tanaka, R.; Komagata, Y.; Misaki, Y.; Yamamoto, K.

The genetic contribution of CTLA‐4 dimorphisms in promoter and exon 1 regions in Japanese patients with rheumatoid arthritis
pp. 154-155(2)
Authors: Takeuchi, F.; Kawasugi, K.; Mori, M.; Nakaue, N.; Kobayashi, N.; Kuwata, S.; Murayama, T.; Matsuta, K.

Dysphagia associated with anti‐PM‐Scl antibodies in systemic lupus erythematosus
pp. 156-157(2)
Authors: Borrows, R.; Chapel, H.; Steuer, A.; Maidment, G.

Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosus
pp. 157-159(3)
Authors: Fiehn, C.; Wilmes, A.; Max, R.; Willand, L.; Löwe, B.; Andrassy, K.; Ho, A. D.; Lorenz, H. ‐M.

Placental cytokine expression and NF‐κB activity in women with rheumatic diseases
pp. 160-162(3)
Authors: Martínez‐Bonilla, G. E.; Muñoz‐Valle, J. F.; Delgado‐Rizo, V.; Martín‐Márquez, B. T.; Ruiz‐Quezada, S. L.; Best‐Aguilera, C. R.; Herrera‐Zárate, L.; Mercado, M. Vázquez‐Del

Methylprednisolone pulse therapy by the Tune–Mendoza protocol in a child with severe Henoch–Schönlein nephritis
pp. 162-163(2)
Authors: Shin, J. I.; Park, J. M.; Kim, J. H.; Lee, J. S.; Jeong, H. J.

Presentations at the annual meeting of The Finnish Society for Rheumatology, Kuopio, 26–27 January 2006
pp. 164-167(4)